Omini
Created in 2019
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
2,632Activities
Technologies
Entity types
Location
15 Rue Jean Antoine de Baïf, 75013 Paris, France
Paris
France
Employees
Scale: 2-10
Estimated: 42
Engaged corporates
6
4 1Added in Motherbase
3 months, 3 weeks ago
deeptech Value proposition
Personalized multiplex blood testing platform to monitor chronic diseases
Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology.
Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.
The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be used at home or in outpatient care facilities to help relieve the burden on healthcare systems.
Omini is currently developing the first application of its solution for heart failure patients, a fast-growing disease nicknamed ‘the silent killer.’
electronics, biology, chemistry, medicine, hardware, and Point-of-careOriginal language
Personalized multiplex blood testing platform to monitor chronic diseases
Founded in 2019, Omini is developing the first point-of-care blood biomarker monitoring platform to transform the lives of patients suffering from chronic diseases, using its unique multiplex electrochemical biosensor technology.
Multiplexing provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.
The affordable device combines a portable reader and single-use test strips, similar to a glucometer, simultaneously measuring four to ten blood biomarkers from a single capillary blood sample. It can be used at home or in outpatient care facilities to help relieve the burden on healthcare systems.
Omini is currently developing the first application of its solution for heart failure patients, a fast-growing disease nicknamed ‘the silent killer.’
Home | Omini
https://www.ominilabs.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Le Catalyseur Government Administration | Le Catalyseur Government Administration | Other 20 Dec 2024 | | |
 CNRS Research, Research Services | CNRS Research, Research Services | Other 15 Dec 2024 | | |
 X-Novation Center Business Consulting and Services | X-Novation Center Business Consulting and Services | Other 31 Jul 2024 | | |
 Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Eurasanté Startup accelerator & VC, Biotechnology, Biotechnology Research | Other 26 Jul 2024 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 29 Jul 2024 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 19 Jan 2024 | | |